Company: SQM
Filing Date: 2025-06-02
Form Type: 6-K
Source: 0000909037-25-000026
Chunk: 2

Company: CHEMICAL & MINING CO OF CHILE INC
Filing Date: 2025-06-02
Form: 6-K
Chunk 2
---
$   |     |        | 487.4 |       |     |        |     | 547.4 |     |           | -60.0 |      |     | -11 | %   |

| International Lithium Division   |     |              |     | 1Q2025 |      |     |     | 1Q2024 |     |     |     | 2025/2024 |      |     |   |    |
| Lithium and Derivatives          |     | Th. MT (LCE) |     |        |      | 2.7 |     |        |     | 0.0 |     |           |  2.7 |     |   | —% |
| Lithium and Derivatives Revenues |     | MUS$         |     |        | 15.5 |     |     |        |     | 0.0 |     |           | 15.5 |     | — | %  |

During the first quarter of the year, as seen in previous periods, we observed strong commercial activity driven by solid demand—particularly from China, followed by Europe. As a result, we achieved the highest first-quarter sales volumes in the company’s history, with approximately 27% year-on-year growth in volumes. Although prices have continued to decline quarter over quarter since the beginning of 2023, average prices were stable in the first months of 2025 compared to the fourth quarter of 2024. Based on market dynamics observed in recent weeks, we expect realized prices for the second quarter to be lower than those in the first quarter, primarily due to additional supply entering the market. In Australia, production of spodumene concentrate at Mount Holland has met expectations, with the project targeting nameplate capacity by 2026. Construction and commissioning of the refinery are progressing well, with first product expected in the upcoming months. Gross profit (2) for the Lithium and Derivatives segment accounted for 37.2% of SQM’s consolidated gross profit for the three months ended March 31, 2025. Specialty Plant Nutrition (SPN) Revenues from our Specialty Plant Nutrition business line for the three months ended March 31, 2025 totaled US$212.2 million, a slight increase when compared to US$207.8 million reported for the three months ended March 31, 2024. Specialty Plant Nutrition Sales Volumes and Revenues:

|                                                |